![Quotient Bioresearch Holdings Limited logo image](https://www.ta.com/system/uploads/fae/image/asset/3095/xs_Quotient_Bioresearch_DETAIL.jpg 320w,https://www.ta.com/system/uploads/fae/image/asset/3095/sm_Quotient_Bioresearch_DETAIL.jpg 640w,https://www.ta.com/system/uploads/fae/image/asset/3095/md_Quotient_Bioresearch_DETAIL.jpg 1024w,https://www.ta.com/system/uploads/fae/image/asset/3095/lg_Quotient_Bioresearch_DETAIL.jpg 1400w,https://www.ta.com/system/uploads/fae/image/asset/3095/xl_Quotient_Bioresearch_DETAIL.jpg 1800w,https://www.ta.com/system/uploads/fae/image/asset/3095/xxl_Quotient_Bioresearch_DETAIL.jpg 2400w)
Quotient Bioresearch was a UK-based contract research organization holding company.
Quotient’s various divisions provided early-stage and specialist drug development services to the global life science industry. In December 2013, Bridgepoint Development Capital acquired Quotient’s Clinical Division and in February 2016, Pharmaron acquired most of the company’s remaining assets.
Sector
Healthcare | Life Science Tools
Investment Year
2008
Status
Past | Acquired by Bridgepoint Development Capital and Pharmaron
Headquarters
United Kingdom